Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.3455
-0.0090 (-2.54%)
May 16, 2025, 1:22 PM - Market open
Harvard Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -58.05 | -12.41 | -3.42 | -9.52 | -0.29 | -7.81 | Upgrade
|
| Depreciation & Amortization | 7.03 | 7.16 | 7 | 7.58 | 7.62 | 7.63 | Upgrade
|
| Other Amortization | 0.39 | 0.33 | 0.28 | 0.28 | 0.28 | 1.18 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.4 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 47.95 | - | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.59 | 1.59 | 0.63 | - | - | - | Upgrade
|
| Stock-Based Compensation | 3.89 | 4.34 | 5 | 4.41 | 4.17 | 3.65 | Upgrade
|
| Other Operating Activities | -0.34 | 0.36 | 0.34 | -4.31 | -0.33 | 0.58 | Upgrade
|
| Change in Accounts Receivable | 1.71 | 0.97 | 0.81 | 4.78 | -4.29 | 3.11 | Upgrade
|
| Change in Inventory | 1.22 | -0.06 | 1.52 | 0.25 | -5.86 | 0.41 | Upgrade
|
| Change in Accounts Payable | -2.35 | -1.79 | -0.52 | -1.4 | 2.45 | 1.49 | Upgrade
|
| Change in Unearned Revenue | -0.68 | -0.7 | 1.14 | -0.9 | 0.51 | -0.18 | Upgrade
|
| Change in Other Net Operating Assets | 1.97 | 1.64 | 1.65 | -0.02 | -2.99 | -0.72 | Upgrade
|
| Operating Cash Flow | 3.02 | 1.44 | 14.03 | 1.15 | 1.26 | 9.33 | Upgrade
|
| Operating Cash Flow Growth | -77.80% | -89.73% | 1117.71% | -8.72% | -86.48% | 15.98% | Upgrade
|
| Capital Expenditures | -2.51 | -2.64 | -1.79 | -1.59 | -1.2 | -1.15 | Upgrade
|
| Divestitures | - | - | 0.51 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.71 | -0.62 | -0.52 | - | -0.15 | -0.25 | Upgrade
|
| Investment in Securities | 1.42 | 1.92 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -1.8 | -1.34 | -1.8 | -1.59 | -1.35 | -1.4 | Upgrade
|
| Long-Term Debt Issued | - | 8.8 | 4.5 | 7.8 | 4.25 | 61.32 | Upgrade
|
| Long-Term Debt Repaid | - | -8.57 | -15.04 | -9.59 | -4.2 | -66.91 | Upgrade
|
| Net Debt Issued (Repaid) | 0.25 | 0.23 | -10.54 | -1.79 | 0.05 | -5.6 | Upgrade
|
| Issuance of Common Stock | 0.37 | 0.38 | 0.93 | 0.58 | 3.31 | 0.67 | Upgrade
|
| Repurchase of Common Stock | -0.61 | -0.58 | -2.52 | -1.63 | -3.51 | -1.14 | Upgrade
|
| Other Financing Activities | -0.29 | -0.16 | - | - | -0.1 | -1.9 | Upgrade
|
| Financing Cash Flow | -0.28 | -0.13 | -12.13 | -2.84 | -0.25 | -7.97 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.35 | -0.14 | -0.32 | -0.04 | -0.16 | 0.02 | Upgrade
|
| Net Cash Flow | 1.29 | -0.18 | -0.23 | -3.31 | -0.5 | -0.02 | Upgrade
|
| Free Cash Flow | 0.51 | -1.2 | 12.24 | -0.44 | 0.07 | 8.18 | Upgrade
|
| Free Cash Flow Growth | -95.52% | - | - | - | -99.18% | 19.77% | Upgrade
|
| Free Cash Flow Margin | 0.56% | -1.28% | 10.90% | -0.39% | 0.06% | 8.01% | Upgrade
|
| Free Cash Flow Per Share | 0.01 | -0.03 | 0.29 | -0.01 | 0.00 | 0.21 | Upgrade
|
| Cash Interest Paid | 3.27 | 3.24 | 3.8 | 2.31 | 1.58 | 4.88 | Upgrade
|
| Cash Income Tax Paid | - | -0.16 | 0.21 | 0.53 | 0.58 | 0.42 | Upgrade
|
| Levered Free Cash Flow | 5.51 | 4.93 | 13.11 | 10.35 | 4.41 | 12.53 | Upgrade
|
| Unlevered Free Cash Flow | 7.16 | 6.61 | 15.07 | 11.66 | 5.09 | 14.37 | Upgrade
|
| Change in Net Working Capital | -2 | -1.32 | -3.83 | -4.51 | 7.66 | -3.09 | Upgrade
|
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.